Clinical Trial

Analgesic Strategies After Mastectomy: RIB vs RIB + DPIPB

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 10, 2026 (before its estimated March 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This retrospective observational study evaluates postoperative pain outcomes in patients undergoing elective mastectomy who received systemic analgesia, rhomboid intercostal block (RIB), or combined rhomboid intercostal block with deep parasternal intercostal plane block (RIB + DPIPB). Medical records from October 2024 to October 2025 will be reviewed. Primary outcomes include pain scores within the first 24 hours, with secondary outcomes including opioid consumption, additional analgesic requirements, patient satisfaction, and early postoperative complications. All data will be analyzed retrospectively and anonymously.
Trial Details
NCT Number NCT07401602
Lead Sponsor Istinye University
Conditions Postoperative Pain
Enrollment 66 participants
Start Date 2026-02-10
Primary Completion 2026-03-10 (estimated)
Study Completion 2026-03-20 (estimated)
Updated on ClinicalTrials.gov 2026-02-10